Fifth Scientific Kratom Symposium Abstracts Published in Frontiers in Pharmacology

Why it matters

The publication of peer-reviewed symposium abstracts in a top-ranked pharmacology journal marks a step toward legitimizing kratom as a subject of serious scientific inquiry, providing researchers and policymakers a curated resource of current evidence.

The big picture

The Fifth Scientific Kratom Symposium, held at the University of Florida College of Pharmacy in February 2026, brought together nearly 100 scientists from around the world. Organized by SABER (Scientific Association of Botanical Education and Research), the event was the largest kratom-specific research convening to date. NIDA Director Nora Volkow served as keynote speaker. Now, abstracts from the four-day symposium have been formally published in Frontiers in Pharmacology, making the research accessible to the broader scientific community.

Key findings

• Abstracts from the Fifth Scientific Kratom Symposium are now published in Frontiers in Pharmacology, a top-ranked peer-reviewed journal
• The symposium hosted nearly 100 scientists from around the world at the University of Florida College of Pharmacy Lake Nona campus in February 2026
• Research topics covered include kratom alkaloid pharmacology, toxicology, analytical chemistry, clinical research, and regulatory science
• SABER organized the four-day international event with leaders including Drs. Paula Brown, Oliver Grundmann, Christopher McCurdy, and Darshan Singh
• The abstract collection is freely accessible via the Frontiers in Pharmacology abstract book portal

What they say

This publication reflects the rapid growth of rigorous, multidisciplinary research on kratom. Bringing scientists, clinicians, and policymakers together is essential to ensure that decisions about botanicals are grounded in credible evidence, said Dr. Paula Brown, SABER Steering Committee member and co-editor of the symposium proceedings.

Bottom line

With nearly 100 scientists presenting and abstracts now published in a leading journal, kratom research has reached a level of critical mass that makes evidence-based regulatory decisions increasingly achievable.